Physician treatment decisions for hormone receptor-positive, HER2-negative early breast cancer in young patients: a Latin American survey
Dana Narváez(Instituto Alexander Fleming), Valeria Caceres(Instituto de Oncología de Rosario), Katherine Muñoz(University of Concepción), Cristian Alexis Ostinelli(Instituto Alexander Fleming), Adrián Nervo(Instituto Alexander Fleming), Cynthia Villarreal‐Garza(Johns Hopkins University), Edgar Danilo Aguirre(Popular University of Cesar), Gonzalo Gómez Abuin(Hospital Alemán), Matías Chacón(Instituto Alexander Fleming), Francisco Ojeda(Universidad Complutense de Madrid), María Paulina Molina Espinosa(Tung Wah Hospital), Ronald Limón(Universidad Privada de Santa Cruz de la Sierra), Claudia Martinez(Honduras Foundation for Agricultural Research), Victoria Costanzo(Instituto Alexander Fleming), Federico Waisberg(Instituto Alexander Fleming), Andrea Aguilar(Instituto de Oncología de Rosario), Pablo Mandó(Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno), Sergio Rivero(Instituto Alexander Fleming), María Lucila González Donna(Instituto Nacional del Cáncer), Vanesa Lopez(Instituto de Oncología de Rosario), S.R. Bella, S.C. Altuna, Alvaro Encinas Casanave(Clínica Alemana), Cinthia Gauna(Instituto Nacional del Cáncer)
Cited by 0
Related Papers
SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe
|European Heart Journal|2021|1.7k
Serial Changes in Highly Sensitive Troponin I Assay and Early Diagnosis of Myocardial Infarction
|JAMA|2011|508
Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts
|Circulation|2017|452
Application of High-Sensitivity Troponin in Suspected Myocardial Infarction
|New England Journal of Medicine|2019|346
Copeptin Improves Early Diagnosis of Acute Myocardial Infarction
|Journal of the American College of Cardiology|2010|336